Analysis of Ischemic Cholangiopathy After Treatment of Arterial Thrombosis in Liver Transplantation in Our Series

Transplant Proc. 2018 Mar;50(2):628-630. doi: 10.1016/j.transproceed.2017.11.062.

Abstract

Liver transplantation offers patients with terminal liver disease an effective treatment accompanied by excellent quality of life, but it also has complications, such as hepatic artery thrombosis and development of ischemic cholangiopathy, described in 3%-17% of patients. It is a very important cause of morbidity and mortality. The objective of this report was to analyze the efficacy of the treatment they received in relation to the development of ischemic cholangiopathy and a comparative survival analysis and to propose prophylactic measures for high-risk patients.

Publication types

  • Observational Study

MeSH terms

  • Bile Duct Diseases / etiology*
  • Female
  • Hepatic Artery / pathology*
  • Humans
  • Ischemia / etiology
  • Liver / blood supply
  • Liver Diseases / etiology
  • Liver Transplantation / adverse effects*
  • Male
  • Retrospective Studies
  • Thrombosis / etiology*
  • Treatment Outcome